THE ECONOMICS OF SOFTWARE QUALITY ASSURANCE.ALBERTS DS.1976; IN: NATL. COMPUT. CONF. PROC.; NEW YORK, N.Y.; 1976; MONTVALE, N.J.; AM. FED. INF. PROCESS. SOC.; DA. 1976; PP. 433-441; BIBL. 1 P. 1/2Conference Paper

CUTANEOUS PLASMACYTOMAS IN MYELOMA: RELATIONSHIP TO TUMOR CELL BURDENALBERTS DS; LYNCH P.1978; ARCH. DERMATOL.; USA; DA. 1978; VOL. 114; NO 12; PP. 1784-1787; BIBL. 26 REF.Article

SAFE, RAPID ADMINISTRATION SCHEDULE FOR CIS-PLATINUM-MANNITOLRAINEY JM; ALBERTS DS.1978; MED. PEDIATR. ONCOL.; USA; DA. 1978; VOL. 4; NO 4; PP. 371-375; BIBL. 19 REF.Article

FAILURE OF DMSO AND VITAMIN E TO PREVENT DOXORUBICIN SKIN ULCERATION IN THE MOUSE = INCAPACITE DU DMSO ET DE LA VITAMINE E DE PREVENIR L'ULCERATION CUTANEE INDUITE PAR LA DOXORUBICINE CHEZ LA SOURISDORR RT; ALBERTS DS.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 5; PP. 499-501; ABS. ENG; BIBL. 17 REF.Article

COMBINATION CHEMOIMMUNOTHERAPY FOR ADVANCED RENAL CARCINOMA WITH ADRIAMYCIN, BLEOMYCIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PLUS BCGDANA BW; ALBERTS DS.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 2; PP. 205-207; BIBL. 16 REF.Article

MODULATION OF EXPERIMENTAL DOXORUBICIN SKIN TOXICITY BY BETA -ADRENERGIC COMPOUNDSDORR RT; ALBERTS DS.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 6; PP. 2428-2432; BIBL. 30 REF.Article

ADRIAMYCIN-CYCLOPHOSPHAMIDE TREATMENT OF SQUAMOUS CELL CARCINOMA OF THE CERVIX.ALBERTS DS; IGNOFFO R.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 1; PP. 143-144; BIBL. 9 REF.Article

DNA SYNTHESIS IN MULTIPLE MYELOMA CELLS FOLLOWING CELL CYCLE-NONSPECIFIC CHEMOTHERAPY = SYNTHESE D'ADN DANS LES CELLULES DU MYELOME MULTIPLE APRES CHIMIOTHERAPIE NON SPECIFIQUE DU CYCLE CELLULAIREALBERTS DS; GOLDE DW.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 11; PP. 2911-2914; BIBL. 16 REF.Article

CIMETIDINE ENHANCEMENT OF CYCLOPHOSPHAMIDE ANTITUMOUR ACTIVITYDORR RT; ALBERTS DS.1982; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1982; VOL. 45; NO 1; PP. 35-43; BIBL. 43 REF.Article

PHARMACOLOGIC ANTIDOTES TO EXPERIMENTAL DOXORUBICIN SKIN TOXICITY: A SUGGESTED ROLE FOR BETA-ADRENERGIC COMPOUNDSDORR RT; ALBERTS DS.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1001-1006; BIBL. 31 REF.Article

ADRIAMYCIN (NSC-123127) IN THE TREATMENT OF ALKYLATOR-RESISTANT MULTIPLE MYELOMA: A PILOT STUDYALBERTS DS; SALMON SE.1975; CANCER CHEMOTHERAPY REP.; U.S.A.; DA. 1975; VOL. 59; NO 2; PP. 345-350; BIBL. 14 REF.Article

ALPHA -TOCAPHEROL PRETREATMENT INCREASES ADRIAMYCIN BONE MARROW TOXICITYALBERTS DS; PENG YM; MOON TE et al.1978; BIOMEDICINE; FRA; DA. 1978; VOL. 29; NO 6; PP. 189-191; BIBL. 8 REF.Article

EXPERIMENTAL MODEL OF DOXORUBICIN EXTRAVASATION IN THE MOUSEDORR RT; ALBERTS DS; CHEN HSG et al.1980; J. PHARMACOL. METHODS; ISSN 0160-5402; USA; DA. 1980; VOL. 4; NO 3; PP. 237-250; BIBL. 21 REF.Article

THE STABILITY OF MELPHALAN IN THE PRESENCE OF CHLORIDE IONCHANG SY; EVANS TL; ALBERTS DS et al.1979; J. PHARM. PHARMACOL.; GBR; DA. 1979; VOL. 31; NO 12; PP. 853-854; BIBL. 7 REF.Article

EFFECT OF RENAL DYSFUNCTION IN DOGS ON THE DISPOSITION AND MARROW TOXICITY OF MELPHALANALBERTS DS; CHEN HSG; MASON NL et al.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 43; NO 3; PP. 330-334; BIBL. 10 REF.Article

LACK OF INHIBITION BY OXIPURINOL OF 5-FU TOXICITY AGAINST HUMAN TUMOR CELL LINES = ABSENCE D'INHIBITION PAR L'OXYPURINOL DE LA TOXICITE DU 5FU CONTRE DES LIGNEES DE CELLULES TUMORALES HUMAINESGAREWAL HS; AHMANN FR; ALBERTS DS et al.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 5; PP. 495-498; ABS. ENG; BIBL. 17 REF.; GRAPHArticle

BLEOMYCIN COMPATIBILITY WITH SELECTED INTRAVENOUS MEDICATIONSDORR RT; YEI MEIPENG; ALBERTS DS et al.1982; JOURNAL OF MEDICINE (WESTBURY); ISSN 0025-7850; USA; DA. 1982; VOL. 13; NO 1-2; PP. 121-130; BIBL. 1 P.Article

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY OF A NEW ANTICANCER DRUG, ADCA-PHYSICOCHEMICAL PROPERTIES AND PHARMACOKINETICSYEI MEI PENG; DAVIS TP; ALBERTS DS et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 29; NO 4; PP. 361-369; BIBL. 3 REF.Article

THE LIMITED ROLE OF CORTICOSTEROIDS IN AMELIORATING EXPERIMENTAL DOXORUBICIN SKIN TOXICITY IN THE MOUSEDORR RT; ALBERTS DS; CHEN HSG et al.1980; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1980; VOL. 5; NO 1; PP. 17-20; BIBL. 15 REF.Article

DOSCORUBICIN/B.C.N.U. CHEMOTHERAPY FOR MULTIPLE MYELOMA IN RELAPSEALBERTS DS; DURIE BGM; SALMON SE et al.1976; LANCET; G.B.; DA. 1976; NO 7966; PP. 926-928; BIBL. 12 REF.Article

RUBIDAZONE VS. ADRIAMYCIN: AN EVALUATION OF THEIR DIFFERENTIAL TOXICITY IN THE SPLEEN COLONY ASSAY SYSTEM.ALBERTS DS; VAN DAALEN WETTERS T.1976; BRIT. J. CANCER; G.B.; DA. 1976; VOL. 34; NO 1; PP. 64-68; BIBL. 14 REF.Article

THE EFFECT OF PHENOBARBITAL ON CYCLOPHOSPHAMIDE ANTITUMOR ACTIVITYALBERTS DS; VAN DAALEN WETTERS T.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 8; PP. 2785-2789; BIBL. 20 REF.Article

THE EFFECT OF ALLOPURINOL ON CYCLOPHOSPHAMIDE ANTITUMOR ACTIVITY.ALBERTS DS; VAN DAALEN WETTERS T.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 8; PP. 2790-2794; BIBL. 27 REF.Article

COMPARATIVE PHARMACOKINETICS OF CHLORAMBUCIL AND MELPHALAN IN MANALBERTS DS; CHANG SY; CHEN HSG et al.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 74; PP. 124-131; BIBL. 14 REF.Article

THE STABILITY OF L-PHENYLALANINE MUSTARD IN BILECHANG SY; EVANS TL; ALBERTS DS et al.1978; LIFE SCI.; GBR; DA. 1978; VOL. 23; NO 16; PP. 1697-1701; BIBL. 14 REF.Article